Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Why you should never order a herpes IgM blood test

Jennifer Gunter, MD
Conditions
July 27, 2013
Share
Tweet
Share

Routine screening blood tests for herpes are not recommended by the Centers for Disease Control. When I say routine screening I mean a scenario such as, “I want to get checked for everything, ok?”

Blood tests for herpes do have a place in specific clinical situations, but that’s for another post.

But say you did get a herpes blood test (even though it’s not recommended many people seem to get it done) and it’s positive for something called IgM antibodies. Armed with these results your doctor proceeds to tell you that these results mean you caught herpes recently, so you start to freak out.

Stop right there.

A positive herpes IgM test means nothing. I’ve posted about this before but enough people continue to leave comments on my herpes posts asking about their positive IgM test that it bears repeating.

A herpes IgM test is never, ever, ever indicated. Not ever, because it doesn’t mean much of anything.

“Impossible,” you say. “My doctor ordered it, so it must be a valid test.”

Well, no.

Let’s review antibodies. When we are exposed to infections we make antibodies. Antibodies are proteins produced by the immune system that fight bacteria and viruses, hopefully containing these infections. IgM antibodies are made first, within weeks, but they don’t hang around. Think of them as first responders. IgG antibodies take longer to produce, but once present you typically have them for life.

However, with herpes this response system is a little different. The herpes virus is never cleared by the immune system. Once you stop shedding the virus it takes up shop in the nerves (the dorsal root ganglia to be specific). From time to time the virus is reactivated, either producing ulcers or just asymptomatic shedding of the virus. How often the virus is reactivated and how much virus is shed depends on many factors.

It is this ability to stay dormant and then reactivate that is a defining characteristic of herpes viruses, but this also affects IgM production. When herpes is reactivated, even though it is not a brand new infection, the body often produces IgM. So, the presence of IgM antibodies against herpes don’t tell you if this is a recent infection or a reactivation and so is of no use clinically. In addition, the IgM tests offered by commercial labs have not been well vetted as type specific, meaning they may not reliably distinguish between IgM for herpes type 1 and type 2 (and remember, by the age of 30 almost everyone is positive for heroes type 1).

Just because a lab offers a test doesn’t mean that the test is useful for your medical care or reliable.

Despite this, many people get tested for herpes IgM.

If you are getting a blood test for herpes, ask your doctor specifically what test that means. If your doctor is ordering an IgM test then go somewhere else, because it means they don’t know enough about herpes to be testing you in the first place.

Disclaimer:  This post is not direct medical advice.

ADVERTISEMENT

Jennifer Gunter is an obstetrician-gynecologist and author of The Preemie Primer. She blogs at her self-titled site, Dr. Jen Gunter.

Prev

A watershed moment in my lifetime of treating cancer patients

July 26, 2013 Kevin 1
…
Next

Haunted by an autism diagnosis: A sense of closure after 20 years

July 27, 2013 Kevin 1
…

Tagged as: Infectious Disease

Post navigation

< Previous Post
A watershed moment in my lifetime of treating cancer patients
Next Post >
Haunted by an autism diagnosis: A sense of closure after 20 years

ADVERTISEMENT

More by Jennifer Gunter, MD

  • The Ellen Show broadcasts potentially harmful information about ovarian cancer screening

    Jennifer Gunter, MD
  • Dear science: an appreciation

    Jennifer Gunter, MD
  • Are there too many female OB/GYNs?

    Jennifer Gunter, MD

More in Conditions

  • Mpox isn’t over: A silent epidemic is growing

    Melvin Sanicas, MD
  • How your family system secretly shapes your health

    Su Yeong Kim, PhD
  • The human case for preserving the nipple after mastectomy

    Thomas Amburn, MD
  • Inside the high-stakes world of neurosurgery

    Isaac Yang, MD
  • Why I left the clinic to lead health care from the inside

    Vandana Maurya, MHA
  • One injection dropped LDL by 69 percent. Should we celebrate?

    Larry Kaskel, MD
  • Most Popular

  • Past Week

    • Why your clinic waiting room may affect patient outcomes

      Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • Why transplant equity requires more than access

      Zamra Amjid, DHSc, MHA | Policy
    • The ethical crossroads of medicine and legislation

      M. Bennet Broner, PhD | Conditions
    • How robotics are transforming the next generation of vascular care [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • How robotics are transforming the next generation of vascular care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The high cost of gender inequity in medicine

      Kolleen Dougherty, MD | Physician
    • Mpox isn’t over: A silent epidemic is growing

      Melvin Sanicas, MD | Conditions
    • How your family system secretly shapes your health

      Su Yeong Kim, PhD | Conditions
    • Women physicians: How can they survive and thrive in academic medicine?

      Elina Maymind, MD | Physician
    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 4 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why your clinic waiting room may affect patient outcomes

      Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • Why transplant equity requires more than access

      Zamra Amjid, DHSc, MHA | Policy
    • The ethical crossroads of medicine and legislation

      M. Bennet Broner, PhD | Conditions
    • How robotics are transforming the next generation of vascular care [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • How robotics are transforming the next generation of vascular care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The high cost of gender inequity in medicine

      Kolleen Dougherty, MD | Physician
    • Mpox isn’t over: A silent epidemic is growing

      Melvin Sanicas, MD | Conditions
    • How your family system secretly shapes your health

      Su Yeong Kim, PhD | Conditions
    • Women physicians: How can they survive and thrive in academic medicine?

      Elina Maymind, MD | Physician
    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Why you should never order a herpes IgM blood test
4 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...